Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. - Wikidata - wikimedia - TriplyDB

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

http://www.wikidata.org/entity/Q34348399

about

Biomarkers in autism Maternal infection and immune involvement in autism The role of immune dysfunction in the pathophysiology of autism Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.Vitamin D and Autism Spectrum Disorder: A Literature Review A Non-inflammatory Role for Microglia in Autism Spectrum Disorders Does Rubella Cause Autism: A 2015 Reappraisal?The Impact of Neuroimmune Alterations in Autism Spectrum Disorder Consensus paper: pathological role of the cerebellum in autism Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment ROS and brain diseases: the good, the bad, and the ugly Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis Hyperbaric oxygen treatment in autism spectrum disorders Genetic aspects of autism spectrum disorders: insights from animal models Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota Tipping the balance of autism risk: potential mechanisms linking pesticides and autism Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study A study of nuclear transcription factor-kappa B in childhood autism Dual oxidase regulates neutrophil recruitment in allergic airways Current progress and challenges in the search for autism biomarkers In search of cellular immunophenotypes in the blood of children with autism An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options.Maternal Immune Activation Causes Behavioral Impairments and Altered Cerebellar Cytokine and Synaptic Protein Expression Interactions of innate and adaptive immunity in brain development and function.Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development.Modeling an autism risk factor in mice leads to permanent immune dysregulation.Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice.Activation of the maternal immune system induces endocrine changes in the placenta via IL-6.Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors.Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities The Gut Microbiota and Autism Spectrum Disorders.Increasing prevalence, changes in diagnostic criteria, and nutritional risk factors for autism spectrum disorders.Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder.Risk factors in autism: Thinking outside the brain.Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity.

P2860

Q21129103-F9662935-CA3B-4270-BE5D-1DDCF2BF6FEC Q22252357-7CA9695B-95A7-488E-AC64-BDB234BA5B6F Q22252518-0CD635AE-F535-4038-8750-8A18CB2D9C19 Q26746354-499048C3-1A8A-4595-8DBF-9B504F32201A Q26748761-BD4A2D08-CE1C-4794-899E-3838B59C78AF Q26750537-1BFB446D-4EC3-4DB8-B5B5-8933C75C80E0 Q26766460-B3593717-02E6-46DC-9C90-B2EFCB7A55F7 Q26766492-D543DB3E-18BE-413F-90AA-77F440FA29C7 Q26781540-DAC15E66-8CFD-43F1-806B-A354787B4CB0 Q26830626-5986F3E5-3DBF-47C3-BA46-65752A1E3EA0 Q27010652-39B59680-980A-40E8-9EE7-BA0C1043B32F Q27011394-05CE5EC3-97BB-4FC9-BDED-7E742442FE72 Q27014070-BBE386D4-5C0D-48AE-ACEA-609DE74A6AD0 Q27024805-1554DC56-2D7F-41F4-8D4A-48D9F1F0E9D2 Q27499262-DDB67944-CE4E-47C3-AC03-3659F5387096 Q27687011-38468600-035F-472D-AD18-4B708746EEF9 Q27928004-83AC678E-460F-4AD1-A686-E60BA5DEDD4A Q28386821-8305CEC0-739E-4BD8-8195-338833F99F10 Q28392778-01553522-F492-446C-B139-19D4177B4A39 Q28397818-D02D1CFE-C8ED-4EF5-BDA8-1F1211DCD504 Q28478093-3BECC5CE-942D-4602-BA98-28F22BC56BE4 Q28588484-526AC1B1-EC86-40CE-B659-E991337BF5AA Q28680718-97DFE649-61C2-4DF2-9243-7F0239C7B888 Q28740461-156A2CFA-5BF9-46F5-8705-AFE09A5FC6EA Q30235878-EC2E4ACB-F111-46D0-858C-2F16BB718B58 Q30355368-31732B77-7CC9-4416-AD04-52C3C46D8407 Q30357060-3776ED57-428E-4CCD-89BD-A75B058FDF74 Q30435550-17621561-47F8-493A-B55B-E0207BB7362C Q30458844-3DF163A6-38D0-4BD7-A70A-3EC40577439B Q30466493-7014BB1E-250E-479C-8B33-4468B59BE671 Q30467965-22B9F667-EE93-4BBC-8293-5A103D8FD4D3 Q30468160-EFA9B586-0407-468E-AA28-F2636A2B2385 Q30573268-E7BDF01D-0250-431A-BFB8-06AD9E7C2139 Q31142266-EE0C48F6-234A-473C-938A-FCC01D48D81A Q33613009-6F40280B-EC9A-4064-8C8C-212CF06A76C0 Q33710383-F23150D9-1665-42F4-B8ED-5B94FA668C61 Q33760025-6E5F9998-7EC6-463A-874A-1E678589192B Q33788661-A2CE34FC-5446-40A6-B5AA-573691EC22C5 Q33840900-A6F32465-C8AF-4B08-98D3-4883FD7FFDAF Q33916678-AF17445A-DA17-4032-ACBF-304EFDFBFA50

P2860

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

http://www.wikidata.org/entity/Q34348399

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@ast

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@en

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@nl

type

label

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@ast

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@en

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@nl

prefLabel

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@ast

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@en

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@nl

P1433

Q34348399-A223A83E-3782-44F4-B75B-4252793C6423

P1476

Q34348399-382F6884-55BD-48CE-8961-1D88732B8B09

P2093

Q34348399-16EF0019-BFB5-4325-B57C-210A71464CA9

Q34348399-403550B4-CE36-4EBF-AC13-68CA9C96CB5C

Q34348399-4174BC2A-87AC-49F5-9779-CC47A4AC2D69

Q34348399-6D8E6DC0-E096-4F2F-9491-3B4ABF9C88A9

Q34348399-EEB4663E-F76F-4BB0-99BE-521E3A663C8C

P2860

Q34348399-00AD582A-E661-4A91-8815-E414B7EE7699

Q34348399-053B9982-E519-45F2-905A-157394FF9EB1

Q34348399-16BC0944-8DEA-447B-8B8F-2975A3235C41

Q34348399-170B80CB-DBC9-425B-9F6A-F2893E7E15D1

Q34348399-18C33A37-7E88-43FB-B7DB-BE1B58FD24C8

Q34348399-19E30C44-74E1-4E76-8596-909521EA1634

Q34348399-1D3B298C-2E39-4C95-B379-ED0F65F4AA4E

Q34348399-22212FA5-7531-4061-83BA-EDF710BC665E

Q34348399-2254529C-B654-4352-B0AC-84733DFA470E

Q34348399-28FDEF9F-C205-41A9-B224-E3A7B77EFA93

P304

Q34348399-44CA87B6-BA7D-4FD2-B357-EF5E629C6447

P31

Q34348399-AB77DE4B-DC40-4A01-B349-5D71D525CFB1

P356

Q34348399-FB2C46A1-3560-49E0-B989-2D5C18887996

P433

Q34348399-2ED4B8A4-0B84-431C-AEF8-20F1C41C55E9

P478

Q34348399-C950B80E-8921-4C0D-9C59-E994443E8134

P50

Q34348399-2077D7F6-5D59-4516-A243-EB9F78BFB51A

P577

Q34348399-953CE1F4-B53A-4830-BD37-EB868CDE1929

P5875

Q34348399-516ECA76-14EB-4AE5-9B09-F087682D7118

P698

Q34348399-334C0179-C749-454B-9B0E-C659F5DD75A9

P921

Q34348399-4FCCD969-3564-4FDC-BF30-7E3DA3E1322F

Q34348399-85F412A7-A3B4-4AF8-8557-4634073952FC

P932

Q34348399-290CE06C-D253-4E77-8428-96A350164CF6

P356

J.BBI.2010.08.003

P1433

Brain, Behavior, and Immunity

P1476

Elevated plasma cytokines in a ...... h impaired behavioral outcome.

@en

P2093

Isaac Pessah

http://www.w3.org/2001/XMLSchema#string

Judy Van de Water

http://www.w3.org/2001/XMLSchema#string

Paul Ashwood

http://www.w3.org/2001/XMLSchema#string

Paula Krakowiak

http://www.w3.org/2001/XMLSchema#string

Robin Hansen

http://www.w3.org/2001/XMLSchema#string

P2860

The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism

Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006

Neuroglial activation and neuroinflammation in the brain of patients with autism

Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury.

Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.

Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10.

Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology.

Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders.

Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention.

P304

40-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBI.2010.08.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Irva Hertz-Picciotto

P577

2010-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45639607

http://www.w3.org/2001/XMLSchema#string

P698

20705131

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

P932

2991432

http://www.w3.org/2001/XMLSchema#string